Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsStem CellsGraft vs Host DiseaseCells, CulturedTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem CellsWhole-Body IrradiationBone and BonesTransplantation ConditioningStem Cell TransplantationAnemia, AplasticLeukemiaTransplantation ChimeraLiver TransplantationGraft SurvivalTissue DonorsBusulfanBone Marrow PurgingHistocompatibility TestingCyclophosphamideHistocompatibilityCombined Modality TherapyHematopoiesisTransplantation, IsogeneicMice, Inbred C57BLCell DifferentiationBone Marrow DiseasesTreatment OutcomeTime FactorsKidney TransplantationRecurrenceRadiation ChimeraLeukemia, Myelogenous, Chronic, BCR-ABL PositiveEmbryonic Stem CellsLeukemia, Myeloid, AcuteHematologic NeoplasmsRemission InductionBone Marrow ExaminationCell ProliferationSurvival AnalysisImmunosuppressive AgentsAdult Stem CellsAntineoplastic Combined Chemotherapy ProtocolsPrecursor Cell Lymphoblastic Leukemia-LymphomaGraft RejectionHepatic Veno-Occlusive DiseaseRetrospective StudiesColony-Forming Units AssayFlow CytometryBone RemodelingBone Marrow NeoplasmsLeukemia, MyeloidTransplantation ImmunologyKidney NeoplasmsGraft vs Host ReactionLymphoma, Non-HodgkinImmunosuppressionMesenchymal Stem Cell TransplantationLymphocyte DepletionSurvival RateCarcinoma, Renal CellChimeraAcute DiseaseLeukocyte TransfusionAntineoplastic AgentsT-LymphocytesFollow-Up StudiesHeart TransplantationDisease-Free SurvivalSevere Combined ImmunodeficiencyPrognosisBreast NeoplasmsMyelodysplastic SyndromesMice, Inbred BALB CHLA AntigensNeoplasmsPluripotent Stem CellsStem Cell NicheHematologic DiseasesCell LineageEtoposideMesenchymal Stromal CellsApoptosisLung TransplantationCyclosporineActuarial AnalysisCell Line, TumorLymphocyte TransfusionBone DensityAntigens, CD34Cell DivisionGranulocyte Colony-Stimulating FactorCell SeparationCell SurvivalReverse Transcriptase Polymerase Chain ReactionHematopoietic Stem Cell Mobilization